Volume 18, Nos. 1 -- 2005
Methadone: an essential analgesic to manage pain in cancer
An interview with Professor Eduardo Bruera
Online resources about prescribing methadone for cancer pain
- CANADA: Conversion protocol to switch to methadone
- CHINA: Conversion protocol to switch to methadone
- GERMANY: Conversion protocol to switch to methadone
- ITALY: Conversion protocol to switch to methadone
- UNITED KINGDOM: Conversion protocol to switch to methadone
- UNITED STATES: Conversion protocol to switch to methadone
- WORLD HEALTH ORGANIZATION: Essential Medicines List (2005)
RESEARCH IN CANCER PAIN AND PALLIATIVE CARE
Methadone: safety, efficacy, patterns of use and barriers to use
- Methadone is effective for relieving cancer pain; analgesic efficacy and side effects are similar to morphine
- Oral methadone vs. sustained-release morphine as first-line treatment of ambulatory cancer patients: similar efficacy and tolerability
- Protocol to switch from morphine to methadone ad libitum
- A safe method to switch from transdermal fentanyl to oral methadone
- Moving from methadone to other opioids is complex
- No link between oral methadone and cardiac toxicity in ambulatory cancer patients
- Low cost of methadone: a barrier to its use for cancer pain
- Patterns of methadone prescribing among UK palliative medicine physicians
- Intermittent subscutaneous administration of methadone: a useful option